Inhibitory Gating Modulation of Small Conductance Ca2+-Activated K+ Channels by the Synthetic Compound (R)-N-(Benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphtylamine (NS8593) Reduces Afterhyperpolarizing Current in Hippocampal CA1 Neurons

SK channels are small conductance Ca2+-activated K+ channels important for the control of neuronal excitability, the fine tuning of firing patterns, and the regulation of synaptic mechanisms. The classic SK channel pharmacology has largely focused on the peptide apamin, which acts extracellularly by a pore-blocking mechanism. 1-Ethyl-2-benzimidazolinone (1-EBIO) and 6,7-dichloro-1H-indole-2,3-dione 3-oxime (NS309) have been identified as positive gating modulators that increase the apparent Ca2+ sensitivity of SK channels. In the present study, we describe inhibitory gating modulation as a novel principle for selective inhibition of SK channels. In wholecell patch-clamp experiments, the compound (R)-N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphtylamine (NS8593) reversibly inhibited recombinant SK3-mediated currents (human SK3 and rat SK3) with potencies around 100 nM. However, in contrast to known pore blockers, NS8593 did not inhibit 125I-apamin binding. Using excised patches, it was demonstrated that NS8593 decreased the Ca2+ sensitivity by shifting the activation curve for Ca2+ to the right, only slightly affecting the maximal Ca2+-activated SK current. NS8593 inhibited all the SK1-3 subtypes Ca2+-dependently (Kd = 0.42, 0.60, and 0.73 μM, respectively, at 0.5 μM Ca2+), whereas the compound did not affect the Ca2+-activated K+ channels of intermediate and large conductance (hIK and hBK channels, respectively). The site of action was accessible from both sides of the membrane, and the NS8593-mediated inhibition was prevented in the presence of a high concentration of the positive modulator NS309. NS8593 was further tested on mouse CA1 neurons in hippocampal slices and shown to inhibit the apaminand tubocurarine-sensitive SK-mediated afterhyperpolarizing current, at a concentration of 3 μM.

[1]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[2]  D. Greenberg,et al.  Calcium channel ‘agonist’ BAY K 8644 inhibits calcium antagonist binding to brain and PC12 cell membranes , 1984, Brain Research.

[3]  G. Giménez-Gallego,et al.  Purification and characterization of a unique, potent inhibitor of apamin binding from Leiurus quinquestriatus hebraeus venom. , 1988, The Journal of biological chemistry.

[4]  Arnold R. Kriegstein,et al.  Whole cell recording from neurons in slices of reptilian and mammalian cerebral cortex , 1989, Journal of Neuroscience Methods.

[5]  A. Kriegstein,et al.  Endogenous neurotransmitter activates N-methyl-D-aspartate receptors on differentiating neurons in embryonic cortex. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[6]  W. Sieghart.  Pharmacology of benzodiazepine receptors: an update. , 1992, Clinical neuropharmacology.

[7]  D. Jenkinson,et al.  Dequalinium: a potent inhibitor of apamin-sensitive K+ channels in hepatocytes and of nicotinic responses in skeletal muscle. , 1993, European journal of pharmacology.

[8]  N. Marrion,et al.  Small-Conductance, Calcium-Activated Potassium Channels from Mammalian Brain , 1996, Science.

[9]  D. Strøbæk,et al.  Modulation of the Ca2+-dependent K+ Channel, hslo, by the Substituted Diphenylurea NS 1608, Paxilline and Internal Ca2+ , 1996, Neuropharmacology.

[10]  J. Foreman,et al.  Textbook of Receptor Pharmacology , 2011 .

[11]  C. Taylor,et al.  Sodium channels and therapy of central nervous system diseases. , 1997, Advances in pharmacology.

[12]  T. Ishii,et al.  Determinants of Apamin and d-Tubocurarine Block in SK Potassium Channels* , 1997, The Journal of Biological Chemistry.

[13]  T. Ishii,et al.  Mechanism of calcium gating in small-conductance calcium-activated potassium channels , 1998, Nature.

[14]  V. Seutin,et al.  Recent advances in the pharmacology of quaternary salts of bicuculline. , 1999, Trends in pharmacological sciences.

[15]  C. Ghelardini,et al.  Effect of potassium channel modulators in mouse forced swimming test , 1999, British journal of pharmacology.

[16]  Max Planck,et al.  An apamin-sensitive Ca 21 -activated K 1 current in hippocampal pyramidal neurons , 1999 .

[17]  F. J. van der Staay,et al.  Behavioral effects of apamin, a selective inhibitor of the SKCa-channel, in mice and rats , 1999, Neuroscience & Biobehavioral Reviews.

[18]  P. Pedarzani,et al.  An apamin-sensitive Ca2+-activated K+ current in hippocampal pyramidal neurons. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  P. Pedarzani,et al.  Differential Distribution of Three Ca2+-Activated K+ Channel Subunits, SK1, SK2, and SK3, in the Adult Rat Central Nervous System , 2000, Molecular and Cellular Neuroscience.

[20]  D. Jenkinson,et al.  Synthesis, Molecular Modeling, and Pharmacological Testing of Bis‐quinolinium Cyclophanes: Potent, Non‐peptidic Blockers of the Apamin‐Sensitive Ca2+‐Activated K+ Channel. , 2000 .

[21]  D. Jenkinson,et al.  Synthesis, molecular modeling, and pharmacological testing of bis-quinolinium cyclophanes: potent, non-peptidic blockers of the apamin-sensitive Ca(2+)-activated K(+) channel. , 2000, Journal of medicinal chemistry.

[22]  A. K. Singh,et al.  Pharmacological activation of cloned intermediate- and small-conductance Ca(2+)-activated K(+) channels. , 2000, American journal of physiology. Cell physiology.

[23]  C. Parsons,et al.  NMDA receptors as targets for drug action in neuropathic pain. , 2001, European journal of pharmacology.

[24]  D. Strøbæk,et al.  KCNQ4 channel activation by BMS-204352 and retigabine , 2001, Neuropharmacology.

[25]  H. J. Olverman,et al.  Characterisation of [125 I]-apamin binding sites in rat brain membranes and HEK293 cells transfected with SK channel subtypes , 2001, Neuropharmacology.

[26]  G. Terstappen,et al.  Distribution of the messenger RNA for the small conductance calcium-activated potassium channel SK3 in the adult rat brain and correlation with immunoreactivity , 2001, Neuroscience.

[27]  K. Chandy,et al.  Design and Characterization of a Highly Selective Peptide Inhibitor of the Small Conductance Calcium-activated K+Channel, SkCa2* , 2001, The Journal of Biological Chemistry.

[28]  B. Fakler,et al.  Control of Electrical Activity in Central Neurons by Modulating the Gating of Small Conductance Ca2+-activated K+ Channels* , 2001, The Journal of Biological Chemistry.

[29]  J. Joseph,et al.  Tamapin, a Venom Peptide from the Indian Red Scorpion (Mesobuthus tamulus) That Targets Small Conductance Ca2+-activated K+ Channels and Afterhyperpolarization Currents in Central Neurons* , 2002, The Journal of Biological Chemistry.

[30]  D. Jenkinson.  Classical approaches to the study of drug-receptor interactions , 2002 .

[31]  Thanos Tzounopoulos,et al.  Small Conductance Ca2+-Activated K+Channels Modulate Synaptic Plasticity and Memory Encoding , 2002, The Journal of Neuroscience.

[32]  J. Scuvée-Moreau,et al.  Modulation of small conductance calcium-activated potassium (SK) channels: a new challenge in medicinal chemistry. , 2003, Current medicinal chemistry.

[33]  M. Kye,et al.  Small conductance Ca2+-activated K+ channels as targets of CNS drug development. , 2004, Current drug targets. CNS and neurological disorders.

[34]  P. Christophersen,et al.  Activation of human IK and SK Ca2+ -activated K+ channels by NS309 (6,7-dichloro-1H-indole-2,3-dione 3-oxime). , 2004, Biochimica et biophysica acta.

[35]  P. Pedarzani,et al.  Matching molecules to function: neuronal Ca2+-activated K+ channels and afterhyperpolarizations. , 2004, Toxicon : official journal of the International Society on Toxinology.

[36]  M. Stocker.  Ca2+-activated K+ channels: molecular determinants and function of the SK family , 2004, Nature Reviews Neuroscience.

[37]  J. Marksteiner,et al.  Comparative immunohistochemical distribution of three small-conductance Ca2+-activated potassium channel subunits, SK1, SK2, and SK3 in mouse brain , 2004, Molecular and Cellular Neuroscience.

[38]  J. Adelman,et al.  SK channels in excitability, pacemaking and synaptic integration , 2005, Current Opinion in Neurobiology.

[39]  D. Strøbæk,et al.  Specific Enhancement of SK Channel Activity Selectively Potentiates the Afterhyperpolarizing Current IAHP and Modulates the Firing Properties of Hippocampal Pyramidal Neurons* , 2005, Journal of Biological Chemistry.

[40]  J. Bizot,et al.  Apamin produces selective improvements of learning in rats , 2005, Neuroscience Letters.

[41]  Jean-François Liégeois,et al.  SK channels control the firing pattern of midbrain dopaminergic neurons in vivo , 2005, The European journal of neuroscience.

[42]  P. Sah,et al.  SK channels regulate excitatory synaptic transmission and plasticity in the lateral amygdala , 2005, Nature Neuroscience.

[43]  B. Sabatini,et al.  SK channels and NMDA receptors form a Ca2+-mediated feedback loop in dendritic spines , 2005, Nature Neuroscience.

[44]  Hua Hu,et al.  Kv7/KCNQ/M and HCN/h, but not KCa2/SK channels, contribute to the somatic medium after‐hyperpolarization and excitability control in CA1 hippocampal pyramidal cells , 2005, The Journal of physiology.

[45]  P. Chavatte,et al.  Identification of a pharmacophore of SKCa channel blockers , 2005, Journal of enzyme inhibition and medicinal chemistry.

[46]  P. Shepard,et al.  SK Ca2+-activated K+ channel ligands alter the firing pattern of dopamine-containing neurons in vivo , 2006, Neuroscience.